At a glance
ClinicalIndex Comparison RecordN/ACompleted· 162 enrolled
Drug / intervention
CP-690,550drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Observational Study To Evaluate Long-Term Safety And Functional Status Of Subjects With Rheumatoid Arthritis Previously Enrolled In Studies Of CP-690,550
In Brief
An observational study evaluating CP-690,550 for Arthritis, Rheumatoid. Completed, enrolled 162 participants across 72 sites in 21 countries.
Detailed Summary
The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Rheumatoid
CountriesArgentina, Brazil, Bulgaria, Canada, Chile, Czechia, Dominican Republic, Finland, Greece, Hungary, India, Italy, Japan, Mexico, Poland, Puerto Rico, Slovakia, South Korea, Spain, Ukraine, United States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 2006
Enrollment StartApr 2007
Primary CompletionFeb 2012
TodayJul 2026
First PostedDec 21, 2006
Enrollment StartApr 1, 2007
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 19.5 years ago
Interventions
CP-690,550drug
Subjects had to have received CP-690,550 or other blinded study drug in index study. No intervention in this long-term follow-up trial.